Concepedia

Laurie Gordon

LG

Statistics

Publications

43

Citations

2.4K

H-Index

28

Active since

1982

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

University of Strathclyde

Molecular Discovery (United Kingdom)

GlaxoSmithKline (Germany)

Age UK

Laurie Gordon is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1982–2022

43

Publications

43

Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition

Natalie H. Theodoulou, Paul Bamborough, Andrew J. Bannister et al. · Journal of Medicinal Chemistry · 2015 · 234 citations · Full text

, , +15

Identification of a novel series of BET family bromodomain inhibitors: Binding mode and profile of I-BET151 (GSK1210151A)

Jonathan T. Seal, Yann Lamotte, Frédéric Donche et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 213 citations · Full text

, , +16

Fragment-Based Discovery of Bromodomain Inhibitors Part 2: Optimization of Phenylisoxazole Sulfonamides

Paul Bamborough, Hawa Diallo, Jonathan D. Goodacre et al. · Journal of Medicinal Chemistry · 2011 · 176 citations · Full text

, , +17

Discovery of Tetrahydroquinoxalines as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for the Second Bromodomain

Robert P. Law, Stephen J. Atkinson, Paul Bamborough et al. · Journal of Medicinal Chemistry · 2018 · 118 citations · Full text

, , +17

Discovery of a Potent, Cell Penetrant, and Selective p300/CBP-Associated Factor (PCAF)/General Control Nonderepressible 5 (GCN5) Bromodomain Chemical Probe

P. G. Humphreys, Paul Bamborough, Chun‐wa Chung et al. · Journal of Medicinal Chemistry · 2016 · 100 citations · Full text

, , +14

1–5 of 43